Log In
Print this Print this

avarofloxacin (JNJ-Q2) (formerly JNJ-32729463)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionFluorinated 4-quinolone topoisomerase inhibitor
Molecular Target DNA gyrase
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today